{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:58:59Z","timestamp":1793350739331,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.vaccine.2010.04.013","type":"journal-article","created":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T08:39:09Z","timestamp":1271925549000},"page":"4175-4180","source":"Crossref","is-referenced-by-count":37,"title":["Persistence of mucosal and systemic immune responses following sublingual immunization"],"prefix":"10.1016","volume":"28","author":[{"given":"Donatella R.M.","family":"Negri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Riccomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Vendetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Cicconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa De","family":"Magistris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2010.04.013_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2006.01.002","article-title":"Mucosal delivery of vaccine antigens and its advantages in pediatrics","volume":"58","author":"De Magistris","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"4 Suppl.","key":"10.1016\/j.vaccine.2010.04.013_bib2","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.vaccine.2010.04.013_bib3","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nri1728","article-title":"Immunization without needles","volume":"5","author":"Mitragotri","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2010.04.013_bib4","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"van Ginkel","year":"2000","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2010.04.013_bib5","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1086\/491739","article-title":"Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines","volume":"192","author":"Armstrong","year":"2005","journal-title":"J Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2010.04.013_bib6","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1128\/JVI.77.18.10078-10087.2003","article-title":"Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system","volume":"77","author":"Lemiale","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.04.013_bib7","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2010.04.013_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.all.0000246617.41871.40","article-title":"Sublingual immunotherapy: update 2006","volume":"6","author":"Passalacqua","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2010.04.013_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/ACI.0b013e3283196764","article-title":"Sublingual immunotherapy: what have we learnt from the \u2018big trials\u2019?","volume":"8","author":"Durham","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2010.04.013_bib10","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/1521-4141(200208)32:8<2274::AID-IMMU2274>3.0.CO;2-C","article-title":"Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant","volume":"32","author":"BenMohamed","year":"2002","journal-title":"Eur J Immunol"},{"issue":"51","key":"10.1016\/j.vaccine.2010.04.013_bib11","doi-asserted-by":"crossref","first-page":"8598","DOI":"10.1016\/j.vaccine.2007.09.073","article-title":"Sublingual immunization induces broad-based systemic and mucosal immune responses in mice","volume":"25","author":"Cuburu","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2010.04.013_bib12","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1073\/pnas.0708684105","article-title":"Sublingual vaccination with influenza virus protects mice against lethal viral infection","volume":"105","author":"Song","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2010.04.013_bib13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-3083.2008.02172.x","article-title":"Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice","volume":"68","author":"Huang","year":"2008","journal-title":"Scand J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2010.04.013_bib14","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.4049\/jimmunol.0803568","article-title":"CCR7-CCL19\/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination","volume":"182","author":"Song","year":"2009","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2010.04.013_bib15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0167-5699(99)01523-6","article-title":"Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins","volume":"20","author":"Rappuoli","year":"1999","journal-title":"Immunol Today"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2010.04.013_bib16","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/S0264-410X(00)00553-3","article-title":"Mucosal vaccines: nontoxic derivatives of LT and CT as mucosal adjuvants","volume":"19","author":"Pizza","year":"2001","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2010.04.013_bib17","doi-asserted-by":"crossref","first-page":"e6999","DOI":"10.1371\/journal.pone.0006999","article-title":"Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin","volume":"4","author":"Lewis","year":"2009","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.vaccine.2010.04.013_bib18","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1128\/IAI.61.10.4272-4279.1993","article-title":"Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant","volume":"61","author":"Jackson","year":"1993","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2010.04.013_bib19","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1128\/IAI.70.10.5533-5539.2002","article-title":"Cholera toxin and heat-labile enterotoxin activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cyclic AMP-dependent pathway","volume":"70","author":"Bagley","year":"2002","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2010.04.013_bib20","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y","article-title":"Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming","volume":"30","author":"Gagliardi","year":"2000","journal-title":"Eur J Immunol"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2010.04.013_bib21","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0264-410X(02)00532-7","article-title":"Maturation of human dendritic cells induced by the adjuvant cholera toxin: role of cAMP on chemokine receptor expression","volume":"21","author":"Gagliardi","year":"2003","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2010.04.013_bib22","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1128\/IAI.01559-08","article-title":"Cholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytes","volume":"77","author":"Negri","year":"2009","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2010.04.013_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/14760584.2.2.285","article-title":"Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines","volume":"2","author":"Peppoloni","year":"2003","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"10.1016\/j.vaccine.2010.04.013_bib24","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.4049\/jimmunol.179.8.5346","article-title":"The acquired immune response to the mucosal adjuvant LTK63 imprints the mouse lung with a protective signature","volume":"179","author":"Tritto","year":"2007","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10005062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10005062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T23:09:42Z","timestamp":1591225782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10005062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":24,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0264410X10005062"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.04.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}